Overview

Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study assessed the bronchodilator efficacy of three different regimens of indacaterol in patients with asthma
Phase:
Phase 2
Details
Lead Sponsor:
Novartis Pharmaceuticals